Tag: nanotechnology
Advances in nanotechnology have important implications for tissue engineering, gene editing, precision medicine, and more.
For instance, WID scientists are advancing the science and engineering of manufacturing scaffolds with the aid of nanotechnology. These scaffolds will give cells a place to adhere while dividing, communicating, absorbing nutrients, and disposing of waste. The scaffolds will also provide a platform for various drug delivery modes.
Brady Lundin
Creating and utilizing neural tissue engineering platforms for the study of clinical disease.
Critical Communications Component Made on a Flexible Wooden Film
WID’s Shaoqin “Sarah” Gong is a collaborator on a paper published in Nature Communications in which UW engineers constructed a functional microwave amplifier circuit on a substrate of cellulose nanofibril paper, a wood product.
Human Nature Screening
The the MS Biotechnology program at UW and the Wisconsin Institute for Discovery are partnering to screen the documentary film “Human Nature”, an exploration of gene editing and its implications both biological and ethical.
Chenglong (Belong) Yu
Focusing on the researches of small-diameter vascular grafts and rapid endothelialization
Huaguang Yang
Advance UHMWPE melt processing technologies, such as injection molding, extrusion and compression
Xiuxiu Wang
Research interests focus on design of multi-functional nanocarriers for targeted drug delivery
Tiny Capsules Packed with Gene-Editing Tools Offer Alternative to Viral Delivery of Gene Therapy
An interdisciplinary pair of WID researchers has developed a new nanocapsule delivery method for delivering the CRISPR-Cas9 gene editing tool. The new system could be used for many types of gene therapies.
Shivani Saxena
Engineering cells and organism via genome editing and studying the delivery method for CRISPR/Cas9
New Technique Enables Versatile 3D Control Over Stem Cell-Derived Organoids
WID researchers Randolph Ashton and Tom Turng partnered on a project to create hydrogel molds that will allow them to more precisely control the three-dimensional structures of organoids.
Randolph Ashton Named SCRMC Associate Director
WID’s Randolph Ashton, assistant professor of biomedical engineering, is the new associate director for UW–Madison’s Stem Cell and Regenerative Medicine Center.
UW–Madison Researchers Developing Methods to Edit Genes in Brain Cells
A second WID-led team joins NIH’s Somatic Cell Genome Editing Consortium with a grant to study new methods of delivering the CRISPR/Cas9 system to the brain.
A Stent-Free Future for Common Cardiovascular Ailments
A team of researchers is developing a new approach for maintaining open blood vessels in the wake of surgeries such as angioplasties or bypasses.
WID Researchers Looking to the Future with UW2020 Awards
Investigators from WID are among the recipients of the latest round of UW2020 awards.
Undergraduate Nathan Wang Receives Goldwater Scholarship
The scholarship recognizes promising undergraduates who plan to pursue a PhD or MD/PhD followed by a research career in engineering, mathematics, or the natural sciences.
Small But Mighty: Nanoparticles Can Deliver More Types of Drugs, More Safely
WID researcher Shaoqin Sarah Gong is working to more safely deliver a variety of drugs to treat cancer, heart disease and even blindness.
All-in-One Repair Kit Makes CRISPR Gene Editing More Precise
Error rates as high as 50 percent are a problem when the goal is to correct typos in the DNA that cause genetic disease. Now, a team of researchers led by WID’s Kris Saha has made the fix less mistake-prone.
Randolph Ashton Continues Research into Causes of Lou Gehrig’s Disease
In August 2017, Randolph Ashton received almost $800,000 from the National Institute of Neurological Disorders and Stroke, part of NIH, to continue a five-year research study of Lou Gehrig’s disease (amyotrophic lateral sclerosis, or ALS), after successfully completing its first phase.
UW-Madison to be Partner in Center for Cell Manufacturing Technologies
The National Science Foundation has awarded nearly $20 million to a consortium of universities to support a new engineering research center that will develop transformative tools and technologies for the consistent, scalable, and low-cost production of high-quality living therapeutic cells. Several WID investigators are collaborators on the project.
